Headlines – Page 368 – Healthy Skeptic

Jan 08 2013

WK

By Kevin Roche Headlines No Comments

Wolters Kluwer, a large health information and publisher company, has completed the acquisition of Health Language, a vendor of medical terminology services.

Jan 08 2013

athena

By Kevin Roche Headlines No Comments

athenahealth, a provider-oriented software and services company, has agreed to acquire Epocrates, a point-of-care application vendor for physicians, for around $300 million.

Jan 07 2013

drug side

By Kevin Roche Headlines No Comments

Researchers have identified a new method of predicting whether a drug is likely to cause side effects by using its chemical structure and the structure of its receptors.

Jan 07 2013

md webs

By Kevin Roche Headlines No Comments

Many websites running review of physicians are only relying on an average of only about 2.4 patients per physician, far too small to be an adequate sample for the reviews to be trusted by readers.

Jan 07 2013

treatment cost

By Kevin Roche Headlines No Comments

New research suggests that consumers believe there is a link between the likelihood of getting a disease and the cost of its treatment; the higher the treatment cost, the less likely people are to think they will catch the disease.

Jan 07 2013

pros can

By Kevin Roche Headlines No Comments

A comprehensive review of prostate cancer treatment options generally finds that surgery is the least expensive and most efficacious option.

Jan 07 2013

prem inc

By Kevin Roche Headlines No Comments

Wellmark, the Iowa Blues plan, is proposing double digit price increases, raising consumer ire. Another example of how the reform law has not reduced premiums, as claimed.

Jan 03 2013

press ganey acq

By Kevin Roche Headlines No Comments

Press Ganey, a large patient satisfaction services vendor, has acquired Morehead Associates, a physician engagement firm.

Jan 03 2013

caci acq

By Kevin Roche Headlines No Comments

Large health care IT vendor CACI International acquired IDL Solutions to bolster its product line.

Jan 03 2013

fda

By Kevin Roche Headlines No Comments

The FDA approved 39 new drugs in 2012, more than in the last 16 years, reflecting better agency processes or better development work by manufacturers, or both. Consumers, however, will pay much more for these drugs than for generics.